With so many biosimilars in the pipeline, the federal government has its hands full. To better understand what Fall has in store, we spoke with Dr. Sarfaraz Niazi.
Oscar Health Tuesday reported a quarterly loss of $15 million thanks in part to tens of thousands of fewer sales of individual health insurance policies.
The SELECT trial is a game changer. Yes, Novo Nordisk achieved winning results. But obesity patients with heart disease now have a major new drug to extend their lives – and that’s an even bigger win.
Health insurers who sell individual coverage under the Affordable Care Act known as Obamacare are average premium increases of 6% for 2024, a new analysis shows.